NEW YORK (GenomeWeb) – CareDx reported after the close of the market on Friday that its fourth quarter revenues rose 65 percent.

For the three months ended Dec. 31, CareDx reported revenues of $10.9 million, up from $6.6 million in Q4 2015, and in line with analyst estimates for revenues of $10.9 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.